AGM/EGMJun 26, 2026, 04:33 PM
Cellectis Shareholders Approve Financials, Board, Capital Actions
AI Summary
Cellectis S.A. shareholders held a Combined General Meeting, approving all but one of the proposed resolutions. Key approvals included the 2025 annual and consolidated financial statements, the renewal of four Board of Directors members, and authorizations for share buybacks and various capital increases. A proposal to increase share capital for a company savings plan was rejected by shareholders.
Key Highlights
- Approved 2025 annual and consolidated financial statements with 99.94% of votes.
- Renewed four Board of Directors members, including Jean-Pierre Garnier, with 94.06% to 99.73% approval.
- Authorized the Board to buy back shares and reduce share capital by cancelling shares with over 99% approval.
- Approved multiple delegations for capital increases, including with cancellation of preferential subscription rights, with 95.25% to 99.45% approval.
- Rejected the delegation to increase share capital for a company savings plan with 85.19% of votes against.
Price Impact
More from CLLS